KR20230005637A - Companion animal therapy powder - Google Patents
Companion animal therapy powder Download PDFInfo
- Publication number
- KR20230005637A KR20230005637A KR1020210086594A KR20210086594A KR20230005637A KR 20230005637 A KR20230005637 A KR 20230005637A KR 1020210086594 A KR1020210086594 A KR 1020210086594A KR 20210086594 A KR20210086594 A KR 20210086594A KR 20230005637 A KR20230005637 A KR 20230005637A
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- companion animal
- weight
- skin
- oil
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 49
- 241001465754 Metazoa Species 0.000 title claims abstract description 30
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 19
- 239000000341 volatile oil Substances 0.000 claims abstract description 43
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 229920002261 Corn starch Polymers 0.000 claims abstract description 12
- 239000008120 corn starch Substances 0.000 claims abstract description 12
- 229940099112 cornstarch Drugs 0.000 claims abstract description 12
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 12
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 11
- 229960000458 allantoin Drugs 0.000 claims abstract description 11
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 11
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 39
- 229930003427 Vitamin E Natural products 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 239000011709 vitamin E Substances 0.000 claims description 14
- 235000019165 vitamin E Nutrition 0.000 claims description 14
- 229940046009 vitamin E Drugs 0.000 claims description 14
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 13
- 229930003799 tocopherol Natural products 0.000 claims description 11
- 235000010384 tocopherol Nutrition 0.000 claims description 11
- 239000011732 tocopherol Substances 0.000 claims description 11
- 229960001295 tocopherol Drugs 0.000 claims description 11
- 244000166124 Eucalyptus globulus Species 0.000 claims description 8
- 239000010501 lemon oil Substances 0.000 claims description 8
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 7
- 241000018646 Pinus brutia Species 0.000 claims description 7
- 235000011613 Pinus brutia Nutrition 0.000 claims description 7
- 239000010632 citronella oil Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000010665 pine oil Substances 0.000 claims description 7
- 235000005979 Citrus limon Nutrition 0.000 claims description 6
- 244000131522 Citrus pyriformis Species 0.000 claims description 6
- 244000166675 Cymbopogon nardus Species 0.000 claims description 6
- 235000018791 Cymbopogon nardus Nutrition 0.000 claims description 6
- 241000208152 Geranium Species 0.000 claims description 6
- 239000010627 cedar oil Substances 0.000 claims description 6
- 239000010648 geranium oil Substances 0.000 claims description 6
- 239000010642 eucalyptus oil Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000011363 dried mixture Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 3
- 210000004243 sweat Anatomy 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 230000003612 virological effect Effects 0.000 abstract description 2
- 208000000260 Warts Diseases 0.000 abstract 1
- 201000010153 skin papilloma Diseases 0.000 abstract 1
- 201000000195 skin tag Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 25
- 230000006870 function Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 235000014380 magnesium carbonate Nutrition 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
- 235000019501 Lemon oil Nutrition 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- -1 oxides Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 3
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 3
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 3
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 229930006722 beta-pinene Natural products 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 3
- 235000019717 geranium oil Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000000749 insecticidal effect Effects 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 159000000003 magnesium salts Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229930003802 tocotrienol Natural products 0.000 description 3
- 239000011731 tocotrienol Substances 0.000 description 3
- 235000019148 tocotrienols Nutrition 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- YMBFCQPIMVLNIU-SOUVJXGZSA-N (-)-exo-alpha-bergamotene Chemical compound C1[C@@H]2[C@@](CCC=C(C)C)(C)[C@H]1CC=C2C YMBFCQPIMVLNIU-SOUVJXGZSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010065369 Burnout syndrome Diseases 0.000 description 2
- DZNVIZQPWLDQHI-UHFFFAOYSA-N Citronellyl formate Chemical compound O=COCCC(C)CCC=C(C)C DZNVIZQPWLDQHI-UHFFFAOYSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- ZJSIKVDEOWWVEH-UHFFFAOYSA-N alpha-himachalene Chemical compound C=C1CCCC(C)(C)C2C1CCC(C)=C2 ZJSIKVDEOWWVEH-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- BQOFWKZOCNGFEC-UHFFFAOYSA-N carene Chemical compound C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000000484 citronellol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229930009515 himachalene Natural products 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- 208000013465 muscle pain Diseases 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- ZLJPQFLGGAYZAN-UMVBOHGHSA-N (4ar,9r,9ar)-4,4,6,9a-tetramethyl-2,3,4a,7,8,9-hexahydro-1h-benzo[7]annulen-9-ol Chemical compound O[C@@H]1CCC(C)=C[C@@H]2C(C)(C)CCC[C@]21C ZLJPQFLGGAYZAN-UMVBOHGHSA-N 0.000 description 1
- OJEFBZMKKJTKKK-UELRPHRMSA-N (5E)-2-methyl-6-[(1R)-4-methylcyclohex-3-en-1-yl]hepta-2,5-dien-4-one Chemical compound O=C(/C=C(\C)/C)/C=C(\C)/[C@H]1CC=C(C)CC1 OJEFBZMKKJTKKK-UELRPHRMSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- LCOSCMLXPAQCLQ-AWEZNQCLSA-N (R)-β-himachalene Chemical compound C1CC(C)=C[C@H]2C1=C(C)CCCC2(C)C LCOSCMLXPAQCLQ-AWEZNQCLSA-N 0.000 description 1
- YSTPAHQEHQSRJD-UHFFFAOYSA-N 3-Carvomenthenone Chemical compound CC(C)C1CCC(C)=CC1=O YSTPAHQEHQSRJD-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- TWQNTLGPLUWKGL-UHFFFAOYSA-N Allohimachalol Natural products CC1=CC2C(O)C(C)(CCCC2(C)C)CC1 TWQNTLGPLUWKGL-UHFFFAOYSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013496 Disturbance in attention Diseases 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- BBAMLNIPVMLTSQ-VNHYZAJKSA-N Himachalol Chemical compound C([C@]1(O)C)CCC(C)(C)[C@@H]2[C@H]1CCC(C)=C2 BBAMLNIPVMLTSQ-VNHYZAJKSA-N 0.000 description 1
- BBAMLNIPVMLTSQ-UHFFFAOYSA-N Himachalol Natural products CC1(O)CCCC(C)(C)C2C1CCC(C)=C2 BBAMLNIPVMLTSQ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241000745334 Nardus Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- JGINTSAQGRHGMG-SOUVJXGZSA-N alpha-trans-bergamotenol Natural products C1[C@@H]2[C@@](CCC=C(CO)C)(C)[C@H]1CC=C2C JGINTSAQGRHGMG-SOUVJXGZSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- NPCUVKWCXITFFV-UHFFFAOYSA-N beta-Himachalene Natural products CC1(C)CCCC2(CO2)C3CCC4(C)OC4C13 NPCUVKWCXITFFV-UHFFFAOYSA-N 0.000 description 1
- LCOSCMLXPAQCLQ-UHFFFAOYSA-N beta-himachalene Chemical compound C1CC(C)=CC2C1=C(C)CCCC2(C)C LCOSCMLXPAQCLQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000027499 body ache Diseases 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930006737 car-3-ene Natural products 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- OJEFBZMKKJTKKK-UHFFFAOYSA-N cis-alpha-Atlanton Natural products CC(C)=CC(=O)C=C(C)C1CCC(C)=CC1 OJEFBZMKKJTKKK-UHFFFAOYSA-N 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 150000004583 himachalene derivatives Chemical class 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229930006968 piperitone Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 1
- 150000003505 terpenes Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- YMBFCQPIMVLNIU-UHFFFAOYSA-N trans-alpha-bergamotene Natural products C1C2C(CCC=C(C)C)(C)C1CC=C2C YMBFCQPIMVLNIU-UHFFFAOYSA-N 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000004636 vulcanized rubber Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 150000003772 α-tocopherols Chemical class 0.000 description 1
- 150000003785 γ-tocopherols Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Description
본 발명은 반려동물 테라피 파우더에 관한 것으로서, 구체적으로 반려동물의 피부를 천연 허브의 약리적인 작용으로 보호하고 살균하는 기능이 있는 파우더 조성물에 관한 것이다.The present invention relates to a companion animal therapy powder, and more specifically, to a powder composition having a function of protecting and sterilizing the skin of a companion animal through the pharmacological action of natural herbs.
반려동물 인구 1,500만명 시대를 맞이하여 국내 Petconomy(pet + economy)시장은 급격히 성장하고 있다. 반려동물과 함께 생활하는 사람을 뜻하는 ‘펫팸족(pet+family)’은 2018년 1000만 명, 2019년 1500만 명을 넘었다. 네 집 중 한 집에서는 반려동물을 키우고 있다는 얘기다. 업계에서는 반려동물 관련 시장규모가 2018년 2조8900억 원에서 2020년 5조8000억 원대로 성장하였으며, 앞으로도 연평균 10% 이상의 성장이 전망되고 시장규모 또한 6조원 까지 증가할 것으로 예상되고 있다.With the companion animal population reaching 15 million, the domestic Petconomy (pet + economy) market is growing rapidly. The number of “pet + family,” meaning people who live with companion animals, exceeded 10 million in 2018 and 15 million in 2019. This means that one out of four households has a pet. In the industry, the companion animal-related market size has grown from KRW 2.89 trillion in 2018 to KRW 5.8 trillion in 2020, and is expected to grow at an average annual rate of more than 10% in the future, and the market size is also expected to increase to KRW 6 trillion.
반려동물을 키우는 사람들이 증가하면서 반려동물의 건강 및 미용을 위해 테라피 용품을 구입하여 사용하는 경우도 늘어나고 있다. 반려동물의 스트레스를 완화하고, 기분을 좋게 만들어주기 위해 많은 사람들이 라벤더나 유칼립투스 같은 에센셜 오일을 사용한다. 그러나 에센셜 오일의 성분 중 다수가 휘발성이고, 반려동물에게 독성을 띨 위험이 있다.As the number of people raising companion animals increases, cases of purchasing and using therapy products for the health and beauty of companion animals are also increasing. Many people use essential oils like lavender or eucalyptus to relieve pet stress and improve their mood. However, many of the constituents of essential oils are volatile and pose a risk of being toxic to pets.
에센셜 오일은 식물의 성분을 매우 고농도로 농축한 것이기 때문에 일반적인 아로마 상품과는 차원이 다르게 독하며, 취급에 주의를 요한다. 특히 식물의 성분 중에는 자체 보호 역할을 하는 미량의 독성이 있기도 한데, 평상시에는 먹거나 닿아도 전혀 문제가 없더라도 농축 과정에서 같이 농축된 독성은 상당히 위험하다. 희석되지 않은 원액은 매우 순한 종류가 아닌 경우 절대로 맨살에 닿게 해서는 안 된다. 향도 좋고 몸에 좋다고 그냥 피부에 끼얹으면 위험하다. 한두 방울 정도 닿은 것으로는 별 것 아니라 여겨서 넘길 수 있는데, 산성 성분이 강한 것에 따라서는 매우 위험할 수도 있다.Because essential oils are highly concentrated plant components, they are poisonous on a different level from general aroma products, and require careful handling. In particular, among the components of plants, there are trace amounts of toxicity that play a role in self-protection. Even if there is no problem at all when eaten or touched normally, the toxicity concentrated together during the concentration process is quite dangerous. Undiluted stock should never come into contact with bare skin unless it is of a very mild variety. It smells good and is good for the body, but it is dangerous if you just pour it on your skin. A touch of one or two drops can be considered insignificant, but depending on the acidic content, it can be very dangerous.
특히, 반려동물이 에센셜 오일을 먹게 되면 간이 손상되며, 다량을 먹었다면 동물병원에 데려가야 한다. 또한, 반려동물의 상처 난 피부에 100% 에센셜 오일을 발라선 절대로 안 된다. 에센셜 오일의 휘발성분이 상처를 통해 반려동물의 혈류로 재빠르게 흡수돼, 필수 장기에 손상을 입힐 위험이 있다. 반려동물이 에센셜 오일로 인하여 화학적 화상을 입거나, 침을 흘리거나, 구토한다면 동물병원에 바로 데려가야 한다. 따라서, 반려동물이 무심코 에센셜 오일을 들이마시거나, 빨거나, 몸에 묻히거나, 먹지 못하도록 에센셜 오일을 안전한 곳에 보관하고 사용에 주의해야 한다.In particular, when pets eat essential oils, their livers are damaged, and if they eat a large amount, they should be taken to a veterinary hospital. Also, never apply 100% essential oils to your pet's broken skin. The volatile components of essential oils are quickly absorbed into the pet's bloodstream through wounds, putting them at risk of damaging vital organs. If your pet suffers from chemical burns, drools, or vomits from essential oils, take him to the veterinarian right away. Therefore, it is necessary to store essential oils in a safe place and be careful when using them to prevent pets from inadvertently inhaling, sucking, smearing, or eating essential oils.
종래의 에센셜 오일을 함유하는 테라피 용품은 휘발성이 강한 액체로 되어 있어 흘려 넘치거나 쉽게 증발하여 사용하는데 불편함이 있었다. 이에 본 발명은 에센셜 오일을 함유하여 반려동물의 피부를 보호하고 기생충을 예방하며, 진정기능으로 스트레스를 완화하고, 파우더형태로 제조되어 필요할 때마다 몸에 뿌리기만 하면 되므로 사용하기 편리한 반려동물 테라피용 조성물을 제공하고자 한다.Conventional therapy products containing essential oils are made of highly volatile liquids, which are inconvenient to use because they overflow or evaporate easily. Therefore, the present invention contains essential oil to protect the skin of companion animals, prevent parasites, relieve stress with a soothing function, and is manufactured in a powder form, so that it is easy to use for companion animal therapy because it is simply sprayed on the body whenever necessary. It is intended to provide a composition.
본 발명은 에센셜 오일을 함유하며 파우더 형태로 제조되는 반려동물 테라피용 파우더 조성물을 제공하는 것이다.The present invention is to provide a powder composition for companion animal therapy containing essential oil and prepared in a powder form.
본 발명은 반려동물 테라피 파우더로서, 탄산마그네슘 파우더 78~84중량%, 콘스타치(corn starch) 파우더 8~11중량%, 알란토인 3~7중량% 및 비타민 E(토코페롤) 3~7중량%를 포함하는 혼합물 100 중량부와 에센셜 오일 30 중량부를 포함하고, 상기 에센셜 오일은 시트로넬라, 유칼립투스, 레몬, 파인, 제라늄 및 시더우드 오일을 포함하는 그룹에서 선택되는 하나 이상인 것을 특징으로 할 수 있다.The present invention is a companion animal therapy powder, containing 78 to 84% by weight of magnesium carbonate powder, 8 to 11% by weight of corn starch powder, 3 to 7% by weight of allantoin, and 3 to 7% by weight of vitamin E (tocopherol). It includes 100 parts by weight of the mixture and 30 parts by weight of essential oil, and the essential oil may be at least one selected from the group consisting of citronella, eucalyptus, lemon, pine, geranium and cedarwood oil.
또한, 상기 반려동물 테라피 파우더의 제조방법은 ① 탄산마그네슘 파우더, 콘스타치 파우더 및 알란토인을 배합하는 단계; ② 상기 배합물에 에센셜 오일 또는 비타민 E(토코페롤)을 혼합하는 단계; ③ 상기 혼합물을 건조시키는 단계, ④ 상기 건조된 혼합물을 다시 잘 섞어서 파우더로 만드는 단계; 및 ⑤ 상기 파우더를 병 또는 용기에 넣어 포장하는 단계;를 포함하는 것을 특징으로 할 수 있다.In addition, the method of manufacturing the companion animal therapy powder includes: ① mixing magnesium carbonate powder, cornstarch powder, and allantoin; ② mixing essential oil or vitamin E (tocopherol) with the formulation; ③ step of drying the mixture, ④ step of mixing the dried mixture well again to make a powder; and ⑤ packaging the powder in a bottle or container.
본 발명의 반려동물 테라피 파우더는 땀을 흡수하는 탄산마그네슘, 보습막을 형성하는 콘스타치, 피부 보호에 효과적인 알란토인 및 항박테리아성 에센셜 오일들의 혼합물로서, 진드기 및 집진드기 등을 예방하고 항생제 내성증인 바이러스 질환으로 피부에 쥐젖이나 사마귀 등이 생기는 것을 방지한다. 또한, 에센셜 오일의 진정 기능으로 반려동물이 안정을 찾는데 도움을 준다.The companion animal therapy powder of the present invention is a mixture of magnesium carbonate that absorbs sweat, cornstarch that forms a moisturizing film, allantoin effective for skin protection, and antibacterial essential oil, which prevents ticks and house ticks and treats antibiotic-resistant viral diseases. Prevents the formation of warts or warts on the skin. In addition, the soothing properties of essential oils help pets find peace.
이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다. 또한, 본 발명을 설명함에 있어, 관련된 공지 구성 또는 기능에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명은 생략한다.Hereinafter, a preferred embodiment of the present invention and the physical properties of each component will be described in detail, but this is to be explained in detail so that a person having ordinary knowledge in the art to which the present invention belongs can easily practice the invention, This is not meant to limit the technical spirit and scope of the present invention. In addition, in describing the present invention, if it is determined that a detailed description of a related known configuration or function may obscure the gist of the present invention, the detailed description will be omitted.
본 발명의 반려동물 테라피 파우더는 탄산마그네슘 파우더 78~84중량%, 콘스타치 파우더 8~11중량%, 알란토인 3~7중량%, 비타민 E(토코페롤) 3~7중량%를 포함하는 혼합물 100 중량부와, 에센셜 오일 30 중량부를 포함하는 것을 특징으로 한다.The companion animal therapy powder of the present invention contains 100 parts by weight of a mixture containing 78 to 84% by weight of magnesium carbonate powder, 8 to 11% by weight of cornstarch powder, 3 to 7% by weight of allantoin, and 3 to 7% by weight of vitamin E (tocopherol). , characterized in that it comprises 30 parts by weight of essential oil.
탄산마그네슘(magnesium carbonate, MgCO3)은 탄산의 마그네슘염으로 천연으로는 마그네사이트로 산출되는 무색의 결정 또는 분말이다. 실험실에서는 마그네슘염에 탄산나트륨을 가하면 침전물로서 생기며, 공업적으로는 바닷물 속에 있는 마그네슘염을 이용하는 방법이나, 암모니아법을 이용하여 3수화물을 만들고 이것을 이산화탄소의 기류 속에서 건조시키는 방법 등이 있다. 또, 수산화마그네슘·하소 돌로마이트 소화물(消和物)의 서스펜션(현탁액)에 이산화탄소를 불어넣어도 생긴다. 식품 첨가물의 하나로 제빵 팽창제, 산도 조절제, 발색제, 케이킹 방지제, 색도 유지제 따위로 쓴다. 마그네슘화합물의 제조원료로도 쓰이며, 가황(加黃)고무 혼화제(混和劑)·치약·제산제·단열제·연마제 등으로 사용된다.Magnesium carbonate (MgCO 3 ) is a magnesium salt of carbonic acid and is a colorless crystal or powder naturally produced as magnesite. In the laboratory, when sodium carbonate is added to magnesium salt, it is formed as a precipitate. Industrially, there is a method using magnesium salt in seawater or a method of making trihydrate using the ammonia method and drying it in a stream of carbon dioxide. It also occurs when carbon dioxide is blown into a suspension (suspension) of magnesium hydroxide/calcined dolomite digestate. As one of the food additives, it is used as a baking leavening agent, acidity regulator, color former, anti-caking agent, and color maintainer. It is also used as a raw material for manufacturing magnesium compounds, and is used as a vulcanized rubber admixture, toothpaste, antacid, heat insulating agent, and abrasive.
콘스타치(옥수수전분, corn starch)는 옥수수의 배유부분에서 추출한 녹말로서, 입자가 곱고 안전성과 접착력이 좋은 원료이다. 화장품에 사용될 시에는 피부의 노화 방지를 도우며, 건조함을 막아주어 피부 보습에 도움을 준다. 또한, 수용성 점증제로 화장품의 점도를 조절하는 역할을 하며, 해로운 외부 물질로부터 피부를 보호해 준다. 피부를 매끄럽게 가꾸어 주며, 피지의 노폐물을 흡수하는 성질이 있어 지성 피부나 문제성 피부에도 효과가 좋다.Cornstarch (corn starch) is a starch extracted from the endosperm of corn, and is a raw material with fine particles and good safety and adhesion. When used in cosmetics, it helps prevent aging of the skin and prevents dryness to help moisturize the skin. In addition, it serves to control the viscosity of cosmetics as a water-soluble thickener and protects the skin from harmful external substances. It makes the skin smooth and absorbs sebum wastes, so it is effective for oily skin or problem skin.
알란토인(allantoin)은 주로 여러해살이 풀인 캄프리(comfrey), 상수리나무, 밀의 싹 등에서 추출한 천연물질이다. 각질을 제거하고 피부에 수분을 주어 피부를 부드럽게 하며, 세포의 분아 번식을 증진시켜 피부의 상처에 치유를 돕고, 자극과 항원에 민감한 피부를 보호하는 효과가 있다. 스테로이드 요법이 아닌 치료제로 가려움증이나 아토피 치료에 사용된다. 현재까지 알레르기나 부작용 사례가 없어 화장품의 성분으로 많이 활용되며, 피부보호 작용에 효과적이어서 다른 화학성분보다 훨씬 안전한 것으로 알려졌다. 치약, 양치질 약, 등의 구강 위생제품과 샴푸, 여드름 약, 햇볕에 탄 피부 진정크림, 화장 크림 등의 화장품과 의약품에 사용된다.Allantoin is a natural substance extracted mainly from perennial grasses such as comfrey, oak tree, and wheat sprouts. It removes dead skin cells and softens the skin by providing moisture to the skin, promotes the proliferation of cells to help heal skin wounds, and has the effect of protecting skin sensitive to irritation and antigens. It is a non-steroid therapy and is used to treat itching or atopy. It is widely used as an ingredient in cosmetics as there are no cases of allergy or side effects so far, and it is known to be much safer than other chemical ingredients because it is effective in skin protection. It is used in oral hygiene products such as toothpaste and mouthwash, cosmetics and pharmaceuticals such as shampoo, acne medicine, sunburn soothing cream, and cosmetic cream.
에센셜 오일(Essential Oil)은 방향성 약용식물에서 추출하는 특유의 향과 살균, 진정, 이완 등 치유효능을 가진 고농도의 천연 식물성 오일이다. 식물의 표면이나 조직 내의 특수한 세포에서 만들어지며, 외부 환경으로부터 자신을 방어하고, 번식과 생존을 위해 스스로 만들어 내는 생화학적 성분의 식물 에센스이다. 방향성 약용식물의 꽃, 줄기, 열매, 뿌리, 수지 등에서 추출되며, 식물의 특성에 따라 냉압착법, 수증기 증류법, 용매추출법, 초임계 이산화탄소추출법 등으로 에센셜 오일을 추출한다. 식물 특유의 향을 가진 순수한 천연 식물성 오일로 지용성 액체이지만 끈적임이 없고 가벼우며 대부분 무색이거나 옅은 노란색을 띤다. 에센셜 오일은 휘발성 유기 화합물로 모노테르펜, 세스퀴터펜, 알코올, 페놀, 알데하이드, 케톤, 에스테르, 옥사이드, 락톤과 쿠마린 등 많은 종류의 화학 구성성분으로 이루어져 있는데, 이러한 다양한 구성성분에 따라 특유의 향과 치유 효능을 가지고 있어서, 그 향기를 흡입 시 후각을 자극하거나 피부에 적용시 인간의 감정과 기억, 정신, 신체 상태에 긍정적인 영향을 준다. 아로마테라피는 에센셜 오일의 치유 효능을 통해 스트레스를 해소하고 면역력을 높이고 심신의 균형을 회복시켜 항상성을 유지하도록 돕는 자연요법으로 보안대체의학 중 하나이다. 에센셜 오일은 아로마테라피 뿐만 아니라 의약품, 화장품, 향수, 향료, 비누, 세정제 등의 원료로도 쓰인다.Essential oil is a high-concentration natural vegetable oil with a unique fragrance extracted from aromatic medicinal plants and healing effects such as sterilization, soothing, and relaxation. It is a plant essence of biochemical components made by special cells in the surface or tissue of plants, to defend itself from the external environment, and to reproduce and survive. It is extracted from flowers, stems, fruits, roots, and resins of aromatic medicinal plants, and essential oils are extracted by cold pressing, steam distillation, solvent extraction, and supercritical carbon dioxide extraction depending on the characteristics of the plant. It is a pure natural vegetable oil with a plant-specific scent. It is a fat-soluble liquid, but it is non-sticky and light, and is mostly colorless or pale yellow. Essential oil is a volatile organic compound and consists of many types of chemical components such as monoterpenes, sesquiterpenes, alcohols, phenols, aldehydes, ketones, esters, oxides, lactones and coumarins. It has a healing effect, so when inhaling its fragrance, it stimulates the sense of smell or when applied to the skin, it positively affects human emotions, memory, mental and physical conditions. Aromatherapy is a natural therapy that helps maintain homeostasis by relieving stress, increasing immunity, and restoring balance between the mind and body through the healing effects of essential oils. Essential oils are used not only for aromatherapy, but also as raw materials for medicines, cosmetics, perfumes, fragrances, soaps, and detergents.
본 발명에 사용되는 에센셜 오일은 시트로넬라, 유칼립투스, 레몬, 파인, 제라늄 및 시더우드 등을 포함한다.Essential oils used in the present invention include citronella, eucalyptus, lemon, pine, geranium, and cedarwood.
시트로넬라(Citronella)는 항진균 성분을 가진 대표적인 허브로서, 길고 폭이 좁은 잎과 짧은 줄기를 가진 다년생 풀로 볏과 식물이다. 시트로넬라 오일은 활력을 증진시키는 향을 가지고 있어서 노이로제 및 신경의 피로를 경감해 준다. 또한 관절염 및 류머티즘의 통증, 근육통, 신경통의 경감에 사용하며, 시트로넬라 오일에 포함된 알데히드 성분은 몸살, 감기, 가벼운 감염에 효과적인 치료성분이 된다. 또한 시트로넬라 오일은 살충효과도 있기 때문에 스프레이 형태로 공기 중에 확산시키는 등으로 간접사용할 수 있다.Citronella is a representative herb with antifungal properties, a perennial herb with long narrow leaves and short stems, and is a crested plant. Citronella oil has a scent that promotes vitality, so it relieves neurosis and nerve fatigue. It is also used to relieve pain from arthritis and rheumatism, muscle pain, and neuralgia, and the aldehyde component contained in citronella oil is an effective treatment ingredient for body aches, colds, and mild infections. Citronella oil also has an insecticidal effect, so it can be used indirectly by dispersing it in the air in the form of a spray.
nardus type의 시트로 넬라 오일은 citronellol(8.4%), geraniol(18%), α-pinene(2.6%), camphene(8%), limonene(9.7%), β-caryophllene(3.2%), 4-terpinenol(0.7%) 등의 성분을 포함하는 것으로 알려져있다.Citronella oil of nardus type was citronellol (8.4%), geraniol (18%), α-pinene (2.6%), camphene (8%), limonene (9.7%), β-caryophllene (3.2%), 4- It is known to contain components such as terpinenol (0.7%).
레몬(Lemon)은 6~9m까지 자라는 사철 푸른 나무로, 옅은 녹색의 달걀형 잎과 강한 향을 풍기는 흰색, 분홍색의 꽃이 피고, 초록색에서 노란색으로 변하는 타원형의 열매가 맺힌다. 열매에는 방부, 항미생물, 항류머티즘, 저혈압성, 지혈, 수렴, 살충, 구충, 살균, 구풍(驅風), 반흔 형성, 정화 등에 효과가 있다. 레몬 오일은 분위기를 고조시키는 효과로 유명하다. 즉, 정신을 고무시키고 정신적 피로를 극복하게 하는 작용을 한다. 레몬 오일은 효과적으로 정신을 명료하게 만들고, 정신을 지나치게 자극하지 않으면서 결정력을 높여 준다고 알려져 있다. 또한 레몬 오일은 감정적으로 지나치게 긴장된 사람을 이완시키는 효과가 우수하다. 그리고 순환계 강화 효과도 뛰어나며, 혈액의 점성률을 낮추고, 동맥 내 혈소판 침적물의 분쇄를 도우며, 콜레스테롤을 감소시킨다. 또한 레몬 오일의 항미생물 특성은 감기, 인플루엔자, 기관지염, 그리고 천식 치료에 매우 효과적이다.Lemon is a perennial green tree that grows up to 6 to 9 m tall, with light green egg-shaped leaves, strong scented white and pink flowers, and green to yellow oval fruits. The fruit is effective in antiseptic, antimicrobial, antirheumatic, hypotensive, hemostasis, astringent, insecticidal, anthelmintic, sterilizing, carminative, scar formation, and purification. Lemon oil is known for its uplifting effect. In other words, it works to inspire the spirit and overcome mental fatigue. Lemon oil is said to effectively increase mental clarity and enhance decision-making without overstimulating the mind. Also, lemon oil is excellent for relaxing people who are overly emotionally tense. It also has excellent circulatory strengthening effects, lowers blood viscosity, helps crush platelet deposits in arteries, and reduces cholesterol. Also, the antimicrobial properties of lemon oil make it very effective in treating colds, influenza, bronchitis, and asthma.
레몬 오일은 limonene 62.41-74.5%, trans α-bergamotene 0.37%, β-pinene 6.1-15.0%, sabinene 1.5-4.6% 등의 성분을 포함하는 것으로 알려져있다.Lemon oil is known to contain components such as limonene 62.41-74.5%, trans-α-bergamotene 0.37%, β-pinene 6.1-15.0%, and sabinene 1.5-4.6%.
유칼립투스(Eucalyptus)는 70m 자라는 교목(喬木)의 속성수로, 수피는 매끄러우며 청회색을 띤 흰색이다. 잎은 엽병 없이 마주나고 회녹색이다. 꽃은 2~3개가 모여 피며 과실은 2.5cm 정도로 동그스름하다. 유칼립투스 오일은 강한 살균작용이 있어 입욕제로 하면 피부를 정화하고 피부 장애에 효과가 있다. 정신 고양, 스트레스 해소에도 효과가 있으며, 가래에는 희석한 오일을 가슴에 바른다. 젊은 피부를 유지하는 효능이 있어 고대 이집트 시대부터 사용되었다. 뜨거운 햇볕에 그을린 피부에 냉각작용을 하며, 벼룩과 이의 살충 효과도 있다.Eucalyptus (Eucalyptus) is a tree tree that grows up to 70m. The leaves are opposite without petioles and are gray-green. Flowers bloom in clusters of 2-3, and fruits are round about 2.5 cm. Eucalyptus oil has a strong bactericidal effect, so when used as a bath, it purifies the skin and is effective for skin disorders. It is also effective in stimulating the mind and relieving stress. Apply diluted oil to the chest for phlegm. It has the effect of maintaining youthful skin and has been used since ancient Egyptian times. It has a cooling effect on sunburned skin and has an insecticidal effect on fleas and lice.
radiat type의 유칼립투스 오일은 1.8cineole 69.10%, piperitone 0.1%, α-pinene 10.66%, β-pinene 0.18%, α-phellandrene 0.09%, limonene 3.29% 등의 성분을 포함하는 것으로 알려져있다.It is known that radiat type eucalyptus oil contains components such as 1.8cineole 69.10%, piperitone 0.1%, α-pinene 10.66%, β-pinene 0.18%, α-phellandrene 0.09%, and limonene 3.29%.
제라늄(Geranium)은 털이 많은 다년생 관목으로 1미터까지 자라며, 끝이 울퉁불퉁한 하트 모양의 잎과 여러 송이의 분홍색 꽃이 핀다. 제라늄 오일은 신경계 조절작용이 우수하여 스트레스, 신경긴장, 우울, 두통, 불안 완화에 사용하며, 스트레스와 과로로 인한 신경성 탈진이 동반된 급성, 만성적 근심에 좋은 효과를 나타낸다. 또한 제라늄 오일은 이뇨성이 있으며, 림프계 촉진효과가 있어서 셀룰라이트, 체액정체, 발목부종의 치료에 유용하며, 항염증과 지혈효과가 뛰어나 습진, 건선, 상처 치료 등에 사용한다. 그리고 부신피질자극제로 호르몬 변동이 문제가 되는 질환의 치료제로 효과적이다.Geranium is a hairy perennial shrub that grows up to 1 m tall, with rugged, heart-shaped leaves and clusters of pink flowers. Geranium oil is excellent in regulating the nervous system, so it is used to relieve stress, nervous tension, depression, headache, and anxiety, and shows good effects on acute and chronic anxiety accompanied by nervous exhaustion due to stress and overwork. In addition, geranium oil has diuretic properties and has a lymphatic system promoting effect, so it is useful for the treatment of cellulite, body fluid retention, and ankle edema, and has excellent anti-inflammatory and hemostatic effects, so it is used in the treatment of eczema, psoriasis, and wounds. In addition, it is an adrenal cortex stimulant and is effective as a treatment for diseases in which hormonal fluctuations are a problem.
제라늄 오일은 citronellol 21.28%, geraniol 17.45%, linalool 12.90%, citronellyl formate 8.37% 등의 성분을 포함하는 것으로 알려져있다.Geranium oil is known to contain 21.28% of citronellol, 17.45% of geraniol, 12.90% of linalool, and 8.37% of citronellyl formate.
파인(Pine)은 사철 푸른 나무로 40m까지 자라고, 나무껍질은 적갈색으로 깊게 층이 패여 있으며 뻣뻣한 청녹색의 침 같은 잎이 난다. 진정 치료, 기능 강화, 항미생물, 항신경통, 방부성, 항바이러스, 살균, 탈취 등에 효과가 있다. 파인 오일은 폐, 신장 및 신경계의 기능강화제로 피로와 신경탈진에 효과적이다. 병의 회복기 또는 허약함을 느낄 때, 심한 심리적 스트레스를 남기는 질병을 겪은 뒤에 기능을 강화하고 부신기능을 돕는 데 사용한다. 그리고 파인 오일은 순환을 촉진하는 효과가 있어서 류머티즘 관절염의 통증완화, 근육통에 도움이 되며 파인의 살균성은 방광염과 신우염 같은 증상에 유용하다. 또한 파인 오일의 거담성, 진정 치료성, 방부 특성은 다양한 유형의 폐 질환에 매우 효과적이며, 감기에서 비롯된 기침, 가래를 깨끗하게 하는 최고의 오일이다. 따라서 부비강 및 기관지 울혈, 기침, 천식, 기관지염에 사용할 수 있다.Pine is a perennial green tree that grows up to 40 m tall, with reddish-brown, deeply layered bark and stiff blue-green needle-like leaves. It is effective in soothing treatment, function enhancement, antimicrobial, antineuralgia, antiseptic, antiviral, sterilization, and deodorization. Pine oil is effective for fatigue and nervous exhaustion as it strengthens the function of the lungs, kidneys and nervous system. It is used to strengthen the function of the adrenal glands and help the adrenal gland function during the recovery period or when feeling weak, after experiencing an illness that leaves severe psychological stress. In addition, pine oil has the effect of promoting circulation, so it is helpful for pain relief of rheumatoid arthritis and muscle pain, and pine's bactericidal properties are useful for symptoms such as cystitis and pyelonephritis. In addition, pine oil's expectorant, sedative, and antiseptic properties make it very effective for various types of lung diseases, and it is the best oil for clearing coughs and phlegm caused by colds. Therefore, it can be used for sinus and bronchial congestion, cough, asthma, and bronchitis.
파인 오일은 monoterpene hydrocarbons 50~97%, α-pinene, 3-carene, ipentene, β-pinene, d-limonene, α-terpinene, γ-terpinene 등의 성분을 포함하는 것으로 알려져있다.Pine oil is known to contain components such as monoterpene hydrocarbons 50-97%, α-pinene, 3-carene, ipentene, β-pinene, d-limonene, α-terpinene, and γ-terpinene.
시더우드(Cedarwood)는 사철 푸른 침엽수로 40~50m까지 크고 넓게 자라며, 줄기나 가지 주위에 여러 겹으로 뾰족한 침처럼 회녹색 나뭇잎이 달린다. 진정, 방부, 수렴, 항지루, 이뇨, 거담, 살충에 효과가 있다. 시더우드 오일은 스트레스, 불안, 긴장을 줄이는 데 사용하며, 몸의 기 에너지를 강장하여 건강하게 만들어 주고 힘을 강화시킨다. 그리고 신장과 비장 모두를 강장하는 효과가 있어서 무기력, 신경쇠약, 요통, 집중력 저하 등에 사용한다. 또한 시더우드 오일은 림프 배수를 증가시키고 축적된 지방의 분해를 촉진하는 효과가 있으며, 세스퀴테르펜 케톤 성분을 함유하여 뛰어난 점액용해 효과가 있어 점액분비 증세, 기침, 만성 기관지염의 치료에 사용할 수 있다.Cedarwood is a perennial green conifer that grows tall and wide up to 40 to 50 m, and has gray-green leaves running around the stem or branches like sharp needles in several layers. It is effective for soothing, antiseptic, astringent, anti-seborrhea, diuretic, expectorant, and insecticide. Cedarwood oil is used to reduce stress, anxiety and tension, and tones the body's qi energy, making it healthy and strengthening. In addition, it has a tonic effect on both the kidney and spleen, so it is used for lethargy, nervous breakdown, back pain, and poor concentration. In addition, cedarwood oil has the effect of increasing lymphatic drainage and promoting the decomposition of accumulated fat. It contains sesquiterpene ketones and has an excellent mucolytic effect, so it can be used for the treatment of symptoms of mucous secretion, cough, and chronic bronchitis. .
Atlas type의 시더우드 오일은 himachalenes 14.5%, α-himachalene 10%, β-himachalene 42%, cis-bisabolrne 1.2%, himachalol 4%, allo-himachalol 2.3%, α-atlantone 2.65%, V-atlantone 5%, himachalene oxide 1% 등의 성분을 포함하는 것으로 알려져있다.Cedarwood oil of Atlas type contains 14.5% of himachalenes, 10% of α-himachalene, 42% of β-himachalene, 1.2% of cis-bisabolrne, 4% of himachalol, 2.3% of allo-himachalol, 2.65% of α-atlantone, and 5% of V-atlantone. , it is known to contain components such as himachalene oxide 1%.
비타민 E(vitamin E)는 지용성 비타민의 일종이며 토코페롤((tocopherol)과 토코트라이에놀(tocotrienol) 계열 화합물을 포함한다. 알파와 감마-토코페롤이 비타민 E의 주요한 성분을 이룬다. 활성 산소의 작용을 억제하는 항산화 작용을 하며, 이에 따라 피부와 혈관 등 각종 세포의 산화를 억제하여 건강 유지에 중요한 역할을 한다. 비타민 E의 과다 복용은 두통이나 출혈을 유발할 수 있으며, 결핍은 용혈성 빈혈이나 신경계통 질환의 원인이 되기도 한다. 비타민 E는 생체 내에서 생성되지 않고 음식물로부터 흡수할 수 있다. 주로 지방을 포함하는 음식에 존재하며, 채소 유래 식용유에 많이 포함되어 있다.Vitamin E is a type of fat-soluble vitamin and includes tocopherol and tocotrienol family compounds. Alpha and gamma-tocopherols form the main components of vitamin E. It plays an important role in maintaining health by suppressing oxidation of various cells such as skin and blood vessels, etc. Overdose of vitamin E can cause headaches or bleeding, and deficiency can cause hemolytic anemia or nervous system diseases. It is also a cause of vitamin E. Vitamin E is not produced in the body but can be absorbed from food.It is mainly present in foods containing fat and is included in vegetable-derived cooking oil.
본 발명에서는 비타민 E의 일종인 토코페롤을 사용하는 것이 바람직하다.In the present invention, it is preferable to use tocopherol, a kind of vitamin E.
토코페롤(tocopherol)은 그리스어 tokos(아이), pherein(낳다) 그리고 알코올 ol의 합성어로 토코트라이엔올((tocotrienol)과 함께 항산화 기능을 가지는 대표적인 비타민 E의 한 종류이다. 아이소프레노이드 곁사슬이 치환된 페놀 구조이며 방향족 고리의 치환기에 따라서 알파, 베타, 감마, 델타 구조가 있으며, 이중 알파-토코페롤이 가장 많고 활성도 제일 높은 것으로 알려졌다. 토코페롤은 항산화제로서 산소 및 다른 유리 라디칼들을 제거하는 역할을 한다. 소수성이므로 생체 내부의 지질 및 세포막, 그리고 혈액 속 지질단백질과 결합하고 있다. 세포막의 지질들이 산소 및 유리 라디칼에 의하여 과산화 작용이 일어나는데, 이때 토코페롤이 존재하면 페놀 고리가 라디칼과 반응하여 세포막 지질의 산화를 막아 세포 손상을 감소시키는 역할을 한다. 이러한 토코페롤의 기능은 세포막의 지질 뿐 아니라, 효소나 여러 단백질들이 붙어있는 지질이중층을 보호한다.Tocopherol is a compound word of the Greek words tokos (child), pherein (to give birth), and alcohol ol, and together with tocotrienol (tocotrienol), is one of the representative types of vitamin E that has an antioxidant function. Isoprenoid side chain is substituted It is a phenol structure, and there are alpha, beta, gamma, and delta structures according to the substituent of the aromatic ring, and among them, alpha-tocopherol is known to have the most and highest activity.Tocopherol serves as an antioxidant to remove oxygen and other free radicals. Since it is hydrophobic, it binds to lipids and cell membranes inside the body and lipoproteins in the blood.Peroxidation of the lipids in the cell membrane occurs by oxygen and free radicals. This function of tocopherol protects not only the lipids in the cell membrane, but also the lipid bilayer to which enzymes and various proteins are attached.
이하, 실시예를 통해 본 발명을 상세히 설명한다. 하기 실시예는 본 발명의 실시를 위하여 예시된 것일 뿐, 본 발명의 내용이 하기 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. The following examples are only exemplified for the practice of the present invention, and the content of the present invention is not limited by the following examples.
본 발명의 반려동물 테라피 파우더의 제조방법은 ① 탄산마그네슘 파우더, 콘스타치 파우더 및 알란토인을 배합하는 단계; ② 상기 배합물에 에센셜 오일 또는 비타민 E(토코페롤)을 혼합하는 단계; ③ 상기 혼합물을 건조시켜 파우더로 만드는 단계; 및 ④ 상기 파우더를 병 또는 용기에 넣어 포장하는 단계;를 포함한다.The method for producing the companion animal therapy powder of the present invention includes: ① mixing magnesium carbonate powder, cornstarch powder, and allantoin; ② mixing essential oil or vitamin E (tocopherol) with the formulation; ③ drying the mixture to make powder; and ④ packaging the powder into a bottle or container.
<실시예> <Example>
① 탄산마그네슘 파우더 70g, 콘스타치 파우더 15g, 알란토인 5g 및 비타민E 10g을 배합하였다.① 70g of magnesium carbonate powder, 15g of cornstarch powder, 5g of allantoin, and 10g of vitamin E were blended.
② 상기 배합물 100중량부에 에센셜 오일 30중량부 추가하여 다시 혼합하였다. 에센셜 오일로는 시트로넬라 에센셜 오일, 유칼립투스 에센셜 오일, 레몬 에센셜 오일, 파인 에센셜 오일, 제라늄 에센셜 오일, 시더우드 에센셜 오일의 조합물을 사용하였다.② 30 parts by weight of essential oil was added to 100 parts by weight of the above mixture and mixed again. As the essential oil, a combination of citronella essential oil, eucalyptus essential oil, lemon essential oil, pine essential oil, geranium essential oil, and cedarwood essential oil was used.
③ 에센셜 오일이 휘발되어 약리적 기능이 상실될 우려가 있으므로, 짧은 시간 자연건조하고, 에센셜 오일과 파우더가 잘 배합될 수 있도록 혼합기에서 5회 반복해서 잘 섞어주었다.③ Since the essential oil may volatilize and lose its pharmacological function, it was naturally dried for a short time and mixed well in a mixer 5 times to mix the essential oil and powder well.
④ 상기 파우더를 밀폐되는 병 또는 용기에 넣어 밀폐포장하였다.④ The powder was put into a hermetically sealed bottle or container and hermetically packed.
본 발명의 반려동물 테라피 파우더는 반려동물의 몸에 적당량 뿌려서 사용한다. 탄산마그네슘 파우더는 땀을 흡수하고, 콘스타치 파우더는 보습막을 형성하며, 알란토인 및 액상 타입 재료는 피부에 흡수되어 반려동물의 피부를 천연 허브의 약리적인 작용으로 보호하고 살균한다. 파우더가 반려동물의 피모에 닿았을 때 피지 등과 함께 섞여 녹아 에센셜 오일의 지용성 성분이 반려동물의 피부에 흡수되며, 진드기가 있는 반려동물에게 사용하였을 때, 피부에서 털 표면으로 진드기가 기어 나오는 사례가 여럿 있었다. 또한, 에센셜 오일의 진정 기능이 부교감 신경계에 작용하여 반려동물이 안정을 찾는데 많은 도움을 준다.The companion animal therapy powder of the present invention is used by sprinkling an appropriate amount on the body of a companion animal. Magnesium carbonate powder absorbs sweat, cornstarch powder forms a moisturizing film, and allantoin and liquid-type ingredients are absorbed into the skin to protect and sterilize the skin of companion animals through the pharmacological action of natural herbs. When the powder touches the fur of a companion animal, it is mixed with sebum and melted, and the fat-soluble components of the essential oil are absorbed into the companion animal's skin. There were several. In addition, the soothing function of essential oils acts on the parasympathetic nervous system, helping pets to find stability.
전술된 바와 같이, 본 발명의 실시예에 따른 반려동물 테라피 파우더는 반려동물의 피부 보호와 기생충 예방에 효과적이며, 진정 기능으로 안정을 찾는데 도움을 준다.As described above, the companion animal therapy powder according to the embodiment of the present invention is effective in protecting the companion animal's skin and preventing parasites, and helps to find stability through its soothing function.
상기와 같이 명세서에 최적의 실시예가 개시되었다. 여기서 특정한 용어들이 사용되었으나, 이는 단지 본 발명을 설명하기 위한 목적에서 사용된 것이지 의미 한정이나 특허청구범위에 기재된 본 발명의 범위를 제한하기 위하여 사용된 것은 아니다. 그러므로, 본 기술 분야의 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 타 실시예가 가능하다는 점을 이해할 것이다. 따라서, 본 발명의 진정한 기술적 보호범위는 첨부된 특허청구범위의 기술적 사상에 의해 정해져야 할 것이다.As described above, an optimal embodiment has been disclosed in the specification. Although specific terms have been used herein, they are only used for the purpose of describing the present invention and are not used to limit the scope of the present invention described in the claims. Therefore, those skilled in the art will understand that various modifications and equivalent other embodiments are possible therefrom. Therefore, the true technical protection scope of the present invention should be determined by the technical spirit of the appended claims.
Claims (4)
탄산마그네슘 파우더 78~84중량%, 콘스타치 파우더 8~11중량%, 알란토인 3~7중량%, 비타민 E(토코페롤) 3~7중량%를 포함하는 혼합물 100 중량부와,
에센셜 오일 30 중량부를 포함하는 것을 특징으로 하는 파우더 조성물.As a companion animal therapy powder composition,
100 parts by weight of a mixture containing 78 to 84% by weight of magnesium carbonate powder, 8 to 11% by weight of cornstarch powder, 3 to 7% by weight of allantoin, and 3 to 7% by weight of vitamin E (tocopherol);
A powder composition comprising 30 parts by weight of essential oil.
상기 에센셜 오일은 시트로넬라, 유칼립투스, 레몬, 파인, 제라늄 및 시더우드 오일을 포함하는 그룹에서 선택되는 하나 이상인 것을 특징으로 하는 파우더 조성물.According to claim 1,
The essential oil is a powder composition, characterized in that at least one selected from the group consisting of citronella, eucalyptus, lemon, pine, geranium and cedarwood oil.
① 탄산마그네슘 파우더 78~84중량%, 콘스타치 파우더 8~11중량%, 알란토인 3~7중량%, 비타민 E(토코페롤) 3~7중량%를 배합하는 단계;
② 상기 배합물 100 중량부와 에센셜 오일 30 중량부를 혼합하는 단계;
③ 상기 혼합물을 건조시키는 단계,
④ 상기 건조된 혼합물을 파우더로 만드는 단계; 및
⑤ 상기 파우더를 병 또는 용기에 넣어 밀폐포장하는 단계;
를 포함하는 것을 특징으로 하는 파우더 조성물의 제조방법.As a method of manufacturing a companion animal therapy powder composition,
① blending 78-84% by weight of magnesium carbonate powder, 8-11% by weight of cornstarch powder, 3-7% by weight of allantoin, and 3-7% by weight of vitamin E (tocopherol);
② mixing 100 parts by weight of the blend and 30 parts by weight of essential oil;
③ drying the mixture;
④ making the dried mixture into a powder; and
⑤ putting the powder in a bottle or container and hermetically packaging it;
Method for producing a powder composition comprising a.
상기 에센셜 오일은 시트로넬라, 유칼립투스, 레몬, 파인, 제라늄 및 시더우드 오일을 포함하는 그룹에서 선택되는 하나 이상인 것을 특징으로 하는 파우더 조성물의 제조방법.
According to claim 3,
The method for producing a powder composition, characterized in that the essential oil is at least one selected from the group consisting of citronella, eucalyptus, lemon, pine, geranium and cedarwood oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210086594A KR20230005637A (en) | 2021-07-01 | 2021-07-01 | Companion animal therapy powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210086594A KR20230005637A (en) | 2021-07-01 | 2021-07-01 | Companion animal therapy powder |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230005637A true KR20230005637A (en) | 2023-01-10 |
Family
ID=84893415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210086594A KR20230005637A (en) | 2021-07-01 | 2021-07-01 | Companion animal therapy powder |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230005637A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200065711A (en) | 2018-11-30 | 2020-06-09 | 한원경 | Composition for improving animal skin diseases |
-
2021
- 2021-07-01 KR KR1020210086594A patent/KR20230005637A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200065711A (en) | 2018-11-30 | 2020-06-09 | 한원경 | Composition for improving animal skin diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006109898A1 (en) | Antimicrobial composition containing natural extract, nano silver and natural essential oil | |
JP2011102245A (en) | Extract of fir tree | |
KR20120063036A (en) | Method for manufacturing handwash and handwash composition thereof containing natural oriental plant extracts | |
KR101765832B1 (en) | Essential Oils with antibacterial substance | |
CN106265147A (en) | A kind of floral water containing natural plant essential oils and preparation method thereof | |
CN108078814A (en) | A kind of plant fragrance fluid composition with mosquito repellent function and its application in cosmetics | |
CN103446247A (en) | High-seepage-force compound essential oil for preventing skins from being aged | |
KR20170122383A (en) | VOCs and stink deodorant with plant material essential oils | |
CN112075459A (en) | Antiviral and antibacterial respiratory tract compound essential oil and preparation method thereof | |
KR100843680B1 (en) | Aromatic composition for relaxation, and solid perfume with it | |
CN102885883B (en) | Lymphatic detox compound essential oil | |
Stiles | The essential oils complete reference guide: Over 250 recipes for natural wholesome aromatherapy | |
CN104644535A (en) | Hair and body wash powder | |
CN104758322A (en) | Composition capable of expelling insects, killing bacteria, sterilizing, and relieving nerve, and applications thereof | |
KR101898060B1 (en) | Natural aroma essential oil water soluble composition for humidifier disinfectant and the method of manufaturing the same | |
KR20230005637A (en) | Companion animal therapy powder | |
KR100505486B1 (en) | Fiber with biological material and its manufacturing method | |
KR102194210B1 (en) | Aromatic composition for preventing or treating motion sickness, nausea and vomiting of pet, and process for preparing the same | |
KR20150006243A (en) | Perfume Composition Containing Chamaecyparis Obtusa Phytoncide | |
Tourles | Stephanie Tourles's Essential Oils: A Beginner's Guide: Learn Safe, Effective Ways to Use 25 Popular Oils; Make 100 Aromatherapy Blends to Enhance Health; Soothe Common Ailments and Promote Well-Being | |
KR20040022829A (en) | pillow comprising dried grasses | |
Curtis et al. | Essential Oils: All-natural remedies and recipes for your mind, body and home | |
Curtis et al. | Neal's Yard Remedies Essential Oils: Restore* Rebalance* Revitalize* Feel the Benefits* Enhance Natural Beauty* Create Blends | |
KR200302707Y1 (en) | pillow comprising dried grasses | |
US20190175392A1 (en) | After-insect bite device and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |